This study aimed to investigate the associations of hepatocyte nuclear factor 4 (HNF4) alpha single nucleotide polymorphisms (SNPs) and haplotype with insulin resistance and metabolic syndrome parameters. Nine SNPs spanning the HNF4 alpha P2 promoter (rs4810424, rs1884613 and rs1884614) and coding region (rs2144908, rs6031551, rs6031552, rs1885088, rs1028583 and rs3818247) were genotyped in 160 subjects without diabetes or metabolic syndrome. The HNF4 alpha P2 promoter SNPs rs4810424, rs1884613 and rs1884614 were associated with insulin resistance (p = 0.017; 0.037; 0.024) and body mass index (BMI) (p = 0.03; 0.035; 0.039). The intron 1D SNP rs2144908 was associated with highdensity lipoprotein cholesterol (HDLc) (p = 0.020) and the intron 9 SNP rs3818247 showed association with systolic (p = 0.02) and diastolic (p = 0.034) blood pressure. HNF4 alpha common haplotype CCCGTC associated with higher insulin resistance (p = 0.022), fasting blood glucose (FBG) (p = 0.035) and lower HDLc (p = 0.001). In conclusion, subjects with HNF4 alpha P2 variants and haplotypes have been shown to have a higher insulin resistance and are therefore at a higher risk for developing type 2 diabetes mellitus.
INTRODUCTION
Insulin resistance and beta cell dysfunction precede the development of intermediate hyperglycaemia and the subsequent type 2 diabetes mellitus (T2DM). Insulin resistance is a feature of a number of diseases including obesity, glucose intolerance, dyslipidemia and hypertension clustering in the so-called metabolic syndrome (Sesti, 2006 ) that together are an indicator of risk for type 2 diabetes mellitus. The prevalence of T2DM in school children is on the increase, which is associated with obesity, metabolic syndrome and insulin resistance (Nathan, 2007; Cali & Caprio, 2008; Holst-Schumacher et al., 2009; Phillips & Phillips, 2009; Amed et al., 2010) . The peripheral insulin resistance refers to diminished insulinmediated uptake of glucose principally by skeletal muscle and adipose tissue, which depends mainly on the control of glucose transporter type 4 (GLUT4) expression and translocation to the plasma membrane (Leclercq et al., 2007) . Hepatic insulin resistance refers to insufficient ability of insulin to suppress hepatic glucose production that account for hyperglycemia. Eighty percent of subjects converted to T2DM are insulin resistant (Haffner et al., 2000) .
Hepatocyte nuclear factor 4 alpha (HNF4 alpha), mostly expressed in the liver and pancreatic beta cells, is a transcriptional factor essential for normal functioning of hepatocytes and endocrine pancreas (Parviz et al., 2003; Odom et al., 2004) . HNF4 alpha controls the expression of several transcription factors (Gonzalez, 2008; Bolotin et al., 2010) and regulates several genes encoding components of insulin secretion and glucose metabolism (Stoffel & Duncan 1997; Wang et al., 2000) . Polymorphisms of HNF4 alpha gene may be associated with insulin resistance. The aim of this project was to study the association of HNF4 alpha P2 promoter SNPs and haplotypes with the insulin resistance and metabolic syndrome parameters (waist circumference, body mass index, fasting blood glucose, C-peptide, systolic and diastolic blood pressure, triglyceride, total cholesterol, LDL and HDL cholesterol).
MATERIALS AND METHODS
Ethical approval was obtained from the National University of Malaysia Research and Ethics committee. The subjects were randomly approached through distribution of brochures to office letterboxes around Cheras area. The Hospital and Faculty of Medicine staffs of University Kebangsaan Malaysia were approached. Brochures were also given to participants to distribute to their relatives and friends. In two years, around nine hundred subjects responded, but after several tries, only 262 were included. After biochemical analysis of their blood, 160 of the 262 were found without diabetes or metabolic syndrome Biochemical analysis. Kits for the measurement of glucose, triglyceride, total cholesterol and HDL cholesterol (reference number 10260, 10724, 10028 and 10018, respectively) were purchased from the Human Company (Human GmbH, Wiesbaden, Germany). Human company Elevated control sera (Humatrol P Reference number 13512) was used as quality control for these parameters. C-peptide was measured in an automated quantitative immunoassay analyzer (Immulite, DPC, Los Angeles, * e-mail: zurina@medic.ukm.my Abbreviations: BMI, body mass index; BP, blood pressure; DHPLC, denaturing high-performance liquid chromatography; BG, fasting blood glucose; HNF4 alpha, hepatocyte nuclear factor 4 alpha; SNP, single nucleotide polymorphism; HDLc, high-density lipoprotein cholesterol, F T2DM, type 2 diabetes mellitus; LDLc, low-density lipoprotein cholesterol; PCR, polymerase chain reaction; TG, triglyceride Vol. 58, No. 2/2011 179-186 on-line at: www.actabp.pl USA) using IMMULITE C-peptide kit (catalogue number LKPE1). Insulin resistance was calculated using the Homeostasis Model Assessment (HOMA2) Calculator v2.2. This program uses fasting C-peptide or insulin and blood glucose measurement to calculate insulin resistance.
Genotype analysis. HNF4 alpha SNPs rs4810424, rs1884613, rs1884614, rs2144908, rs6031551, rs6031552, rs1885088, rs1028583 and rs3818247 were selected for genotypic analysis in based on published results from the Finnish and Ashkenazi Jewish studies (Love-Gregory et al., 2004; Silander et al., 2004) . All SNPs in this research were amplified by in an Icycler thermocycler (Bio-Rad Laboratories, Inc., Richmond, CA, USA) using a 96 microwell plate. Touchdown PCR was applied for all SNPs except rs1884613 which was amplified and identified by allele specific PCR (AS-PCR). Restriction enzymes (New England Biolabs, USA) were used for identifying the genotypes of rs4810424 (BstXI), rs1884614 (BsgI), rs6031551 (MseI), rs6031552 (CvikI-1), rs1885088 (Sau96) and rs1028583 (PstI). The complete procedures of PCR amplification and genotyping of the SNPs are available from the authors.
Rs2144908 and rs3818247 were genotyped by denaturing high-performance liquid chromatography (DHPLC) (Varian Inc, Palo Alto, CA, USA). A recommendation for running rs2144908 and rs3818247 at 60 ºC and 58 ºC, respectively, was obtained when these SNPs PCR amplified sequences were uploaded to the DHPLC melt program (http://insertion.stanford.edu/melt.html). These recommended temperatures were confirmed experimentally by running 5 μl of PCR products of these SNPs on the DHPLC at two degrees below and above. Separated peaks of heteroduplex and homoduplex DNA from heterozygous samples of rs2144908 and rs3818247 were detected at 59 ºC and 57.5 ºC, respectively, using DHPLC program gradient buffer and time. Known heterozygous, homozygous minor and homozygous major genotypes of rs2144908 and rs3818247 (these samples were sequenced) were included into the runs as quality controls which were run at 59 ºC and 57.5 ºC, respectively. Some samples were sequenced by automated 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) using terminator cycle sequencing kit v3.1 to confirm the allele specific PCR and DHPLC results.
Statistics. HelixTree 6.0.1 SNP and Variation Suite for Genetic statistics was used to study the deviation of SNPs from the Hardy-Weinberg equilibrium and to study the linkage disequilibrium between SNPs and construct haplotypes and diplotypes of related SNPs. Other statistical analyses were done by SPSS 11.5 program. The missing data were listwise deleted (when any of the variables were missing, the entire observation was omitted from the analysis). The BMI, waist, systolic and diastolic blood pressure, fasting blood glucose, C-peptide, insulin resistance, total cholesterol, triacylglycerol, HDL and LDL cholesterol data were log transformed because they were not normally distributed. These parameters' means and 95 % confidence intervals were transformed back and reported, and were called geometric means.
The linearity of correlation of metabolic syndrome parameters: insulin resistance, C-peptide, glucose, BMI, waist, systolic BP, diastolic BP, TG, total cholesterol, HDL cholesterol and LDL cholesterol (dependent variables) were analyzed by bivariate correlations, resulting in three sets of dependent variables. The first set was insulin resistance, C-peptide, fasting blood glucose, BMI, waist, triglyceride, and HDL cholesterol. The second set was total cholesterol and LDLc and the third set was systolic and diastolic blood pressure. The association of HNF4 alpha SNPs, haplotypes and diplotypes with these three sets of dependent variables was evaluated by multivariate analyses (general linear model) adjusted for age, sex and race as covariates. Wilks' Lambda test was used for more than two groups of independent variables. Hotelling's Trace was used for two groups of independent variable. The difference between means was considered significant if p-value < 0.05.
RESULTS
The demographic and biochemical parameters of the subjects are summarized in Table 1 . HelixTree program showed no deviation of all the SNPs included in this study from Hardy-Weinberg equilibrium. Five SNPs showed association with metabolic syndrome parameters: rs4810424, rs1884613, rs1884614, rs2144908 and rs3818247, whereas rs6031551, rs6031552 and rs1028583 showed no association. The homozygous minor and heterozygous genotypes frequencies of rs1885088 were very low in our subjects (0.0 and 0.03, respectively) thus the association of this SNP with metabolic syndrome parameters was not studied.
Association of P2 promoter SNP rs4810424 with metabolic syndrome parameters
Multivariate analyses of this SNP with the three sets of metabolic syndrome parameters showed a significant Wilks' Lambda test (P = 0.039) with the first set (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI) whereas the second set (total and LDL cholesterol) and the third set (systolic and diastolic blood pressure) were non-significant ( Table 2 ). The subjects having homozygous GG variant had significantly lower insulin resistance (P = 0.017) and C-peptide levels (P = 0.046) than those with homozygous CC. In addition, the FBG, BMI and LDLc were non-significantly lower in subjects having the homozygous minor GG variant than the homozygous major CC variant (P = 0.055, 0.06, 0.056, respectively), whereas HDLc was non-significantly higher (P = 0.06). The subjects having heterozygous CG of this SNP showed a significantly higher BMI (P = 0.036) and non-significantly higher FBG (P = 0.06) than the subjects carrying homozygous minor GG. The multivariate analysis showed that homozygous minor and heterozygous variants of this SNP were not associated with waist, TG, total cholesterol, systolic and diastolic blood pressure.
Association of P2 promoter SNP rs1884613 with metabolic syndrome parameters
Multivariate analyses of this SNP with the three sets of metabolic syndrome parameters showed a non-significant Wilks' Lambda test with the first set (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI), the second set (total and LDL cholesterol) and the third set (P = 0.131, 0.347, 0.282, respectively) ( Table 3) . Parameter estimates of the multivariate test showed that subjects carrying homozygous minor variant for this SNP had lower insulin resistant and FBG, and higher HDLc than subjects carrying homozygous major variant (P = 0.037, 0.042, 0.038, respectively). The subjects carrying the heterozygous (CG) variant for this SNP had lower HDLc (P = 0.042) and higher BMI (0.035) than those with homozygous minor variant. The homozygous major and heterozygous variants of this SNP were not associated with the other metabolic syndrome parameters (Cpeptide, TG, waist, total and LDL cholesterol, systolic and diastolic blood pressure).
Association of P2 promoter SNP rs1884614 with metabolic syndrome parameters
The SNP multivariate analyses of the three sets of metabolic syndrome parameters showed a non-significant Wilks' Lambda test with the first set (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI), the second set (total and LDL cholesterol) and the third set (systolic and diastolic blood pressure) (P = 0.112, 0.243, 0.395, The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate. The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate.
respectively) (Table 4) . However, parameter estimates of multivariate analyses showed that insulin resistance, Cpeptide and BMI were significant lower in subjects having homozygous minor TT variant than the homozygous major CC subjects (P = 0.024, 0.028, 0.039, respectively). The subjects having homozygous major or heterozygous variant had non-significantly lower HDLc than those with the homozygous minor variant (P = 0.057, 0.060, respectively). The heterozygous and homozygous major variants were not associated with the other metabolic syndrome parameters but the pattern was similar to that for HDLc.
Association of intron 1D SNP rs2144908 with metabolic syndrome parameters
The dependent variables of the first set (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI) showed a significant Wilks' Lambda test (P = 0.036) although the parameter estimates of the multivariate analysis showed that only HDLc was significantly higher among subjects having the homozygous minor (AA) variant than in those carrying the homozygous major one (P = 0.020) ( Table 5 ). In addition, HDLc was border line higher in the subjects having one copy of this SNP minor variant than those subjects having no minor genotype copies (P = 0.054). Wilks' Lambda test for the variables of the second set (total and LDL cholesterol) and the third set (systolic and diastolic blood pressure) were non-significant (P = 0.73, 0.258, respectively) as well as the parameter estimates showed no association of these variables with rs2144908 genotypes.
Association of intron SNP rs3818247 with metabolic syndrome parameters
The multivariate analyses of the three sets of metabolic syndrome parameters indicated a non-significant Wilks' Lambda test with the first set (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI), the second set (total and LDL cholesterol) and the third set (systolic and diastolic blood pressure) ( Table 6 ). The parameter estimates indicated that systolic and diastolic blood pressure were higher among subjects carrying the The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate. The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate. Hepatocyte nuclear factor 4 alpha P2 promoter variants The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate. The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate.
homozygous minor (GG) variant than the subjects carrying the homozygous major (TT) (0.02, 0.034, respectively).
Associations of common haplotypes with metabolic syndrome parameters
Six-SNP haplotype and diplotype blocks were identified with significant LD. This block is constructed from rs24 (rs4810424), rs13 (rs1884613), rs14 (rs1884614), rs08 (rs2144908), rs51 (rs6031551) and rs52 (rs6031552) (Fig. 1) . Wilks' Lambda test of multivariate analysis showed that the most common haplotypes2 were associated with the first set of metabolic syndrome parameters (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI) (P = 0.002). The parameter estimates of this multivariate analysis indicated that subjects carrying the haplotype2, GGTATC, had higher HDLc and lower insulin resistance, C-peptide and FBG than subjects carrying the haplotpe2, CCCGTC (P = 0.001, 0.022, 0.044, 0.035) ( Table 7) . Wilks' Lambda tests and parameter estimates of multivariate analyses of the second set (total and LDL cholesterol) and the third set (systolic and diastolic blood pressure) of metabolic syndrome parameters were not associated with haplotypes2. The most common haplotypes1 (CCCGTC and GGTATC) were not associated with the three sets of metabolic syndrome parameters, however, these haplotypes1 showed a similar pattern to the most common haplotypes2.
Association of the common diplotypes with metabolic syndrome parameters
The association of the most common diplotypes with the first set of metabolic syndrome parameters (insulin resistance, C-peptide, FBG, TG, HDLc, waist and BMI) was border line (Wilks' Lambda test p-value = 0.064) ( Table 8 ). The parameter estimates of these metabolic syndrome parameters indicated that subjects carrying the GGTATC,GGTATC diplotype were less insulin resistant than the subjects carrying the CCCGTC,CCCGTC or GGTATC,CCCGTC diplotype (P = 0.030, 0.071, respectively). In addition, HDLc was higher in subjects having the GGTATC,GGTATC diplotype than in subjects having the CCCGTC,GGTATC or CCCGTC,CCCGTC diplotype (P = 0.018, 0.065, respectively). Wilks' Lambda tests and the parameter estimates of total and LDL cholesterol, systolic and diastolic blood pressure showed that these parameters were not associated with the above most common diplotypes.
DISCUSSION
The results showed that the homozygous major variants for the HNF4 alpha P2 promoter SNPs (rs4810424, rs1884614 and rs1884613) associated with insulin resistance, C-peptide and BMI whereas the intron 1D SNP rs2144908 associated with HDL cholesterol. In addition, the haplotypes2 (CCCGTC) comprising the homozygous major variants of rs4810424, rs1884613, rs1884614, and rs2144908 showed an additional significant association with insulin resistance, C-peptide, fasting blood glucose and HDL cholesterol. The individuals carrying homozygous major variants for these SNPs might be at a higher risk of developing metabolic syndrome (prediabetic stage) and hence T2DM. The risk for developing T2DM will be increased in the subjects carrying the risk haplotype (CCCGTC). The results are presented as geometric mean and 95% confidence interval of the mean adjusted for age, sex and race as covariate.
Figure 1. Linkage disequilibrium correlation between SNPs rs24, rs4810424; rs13, rs1884613; rs14, rs1884614; rs08, rs2144908; rs51, rs6031551; rs52, rs6031552.
